ALT Altimmune
- 8.870
- +1.050+13.43%
- 8.912
- +0.042+0.47%
Altimmune News
Altimmune | 8-K: Altimmune Announces First Quarter 2024 Financial Results and Provides a Business Update
Altimmune | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Altimmune | 8-K: Altimmune Announces Positive Lean Mass Preservation Data for Pemvidutide and Reports Fourth Quarter and Full Year 2023 Financial Results
Altimmune | 8-K: Current report
Altimmune | 8-K: Altimmune Announces Third Quarter 2023 Financial Results and Provides a Business Update
Altimmune | 8-K: Current report
Altimmune | DEF 14A: Definitive information statements
Altimmune | 8-K: Altimmune Announces Second Quarter 2023 Financial Results and Provides a Business Update
Altimmune | 8-K: Altimmune Announces First Quarter 2023 Financial Results and Provides a Business Update
Altimmune | 8-K: Current report
Altimmune | 8-K: Current report
Altimmune | S-3ASR: Automatic shelf registration statement of securities of well-known seasoned issuers
Altimmune | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Altimmune | 8-K: Altimmune Announces Fourth Quarter and Full Year 2022 Financial Results and Provides a Business Update
Altimmune | 8-K: Current report
Altimmune | 8-K: Altimmune Announces Third Quarter 2022 Financial Results and Provides a Business Update
Altimmune | 8-K: Current report
Altimmune | 8-K: Current report
Altimmune | DEF 14A: Definitive proxy statements
Altimmune | 8-K: Altimmune Announces Second Quarter 2022 Financial Results and Provides a Business Update
Analysis
Price Target
No Data
